Before you sell to, join or invest in Epicore Biosystems, Inc.
MentionFox check on Epicore Biosystems, Inc.: only 2 sources on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/epicore-biosystems-inc-form-d-25000001
Check Epicore Biosystems, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Epicore Biosystems, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-01-06.
Epicore Biosystems, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on January 6, 2025. The filing reports $25.69M sold. Its industry group is Biotechnology. It names Roozbeh Ghaffari (Executive Officer, Director), John Rogers (Director), Laura Lang (Director) (SEC Form D/A, January 6, 2025).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Epicore Biosystems, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-01-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Epicore Biosystems, Inc.
Free to see. No signup.
Get an email when Epicore Biosystems, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Epicore Biosystems, Inc. raises, hires or launches. No email unless you switch it on.
Watch Epicore Biosystems, Inc. →Get the full cited report on Epicore Biosystems, Inc.
What the filing shows about Epicore Biosystems, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Epicore Biosystems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Epicore Biosystems, Inc.'s address as 410 Memorial Drive, Suite 100, Cambridge, MA 02139.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-04-07: the number of investors changed from 44 to 4. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Epicore Biosystems, Inc. See pricing
Epicore Biosystems, Inc. is a registered filer with the SEC (CIK 1755876) and has filed since 2024-02-01. 3 filings are on record, the latest on 2025-04-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Epicore Biosystems, Inc.'s Form D of 2025-01-06 names Roozbeh Ghaffari, John Rogers, Laura Lang and 7 more as its officers, directors or promoters.
Its new offerings report $27.23M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Roozbeh Ghaffari is named as Executive Officer and Director on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
John Rogers is named as Director on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
Laura Lang is named as Director on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
Kimberly Querrey is named as Director on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
Stephen Lee is named as Executive Officer on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
John Wright is named as Executive Officer on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
Alexander Aranyosi is named as Executive Officer on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
James Ryan is named as Executive Officer on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
Jeffrey Model is named as Executive Officer on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
Weihua Li is named as Executive Officer on the Form D that Epicore Biosystems, Inc. filed with the SEC on 6 January 2025, one of 10 people that filing names.
10 people named on the filing — 7 holding an executive role and 3 as directors only.
Named as of the 2025-01-06 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Epicore Biosystems, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Epicore Biosystems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Epicore Biosystems, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Epicore Biosystems, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Epicore Biosystems, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Epicore Biosystems, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/epicore-biosystems-inc-form-d-25000001